Feedback (LON:FDBK)‘s stock had its “corporate” rating reiterated by equities research analysts at Northland Securities in a research report issued on Monday, February 26th.
Feedback (LON FDBK) traded down GBX 0.17 ($0.00) during mid-day trading on Monday, reaching GBX 1.45 ($0.02). 519,152 shares of the company were exchanged, compared to its average volume of 1,080,000. Feedback has a one year low of GBX 1.35 ($0.02) and a one year high of GBX 5.20 ($0.07).
TRADEMARK VIOLATION WARNING: “Northland Securities Reaffirms “Corporate” Rating for Feedback (LON:FDBK)” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://ledgergazette.com/2018/03/15/feedback-fdbk-rating-reiterated-by-northland-securities-2.html.
Feedback plc is a United Kingdom-based medical imaging software company. The Company is engaged in providing imaging tools for clinical decision makers. The Company is engaged in developing techniques and managing workflow for medical practitioners involved in research and in treating patients. The Company offers TexRAD, which is engaged in providing medical research and it can be used to manage clinical trials and helps to manage pharmaceuticals.
Receive News & Ratings for Feedback Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Feedback and related companies with MarketBeat.com's FREE daily email newsletter.